The second phase of New Zealand's High-Value Nutrition National Science Challenge will see a significant portion of its work focused on China, alongside New Zealand and Singapore.
Read about Blackmores' strategy overhaul in the wake of weak Q3 results, Bod Australia's continuing CBD innovations, Sirio Pharma's global R&D plans, and probiotics news from BLIS Technologies and Indian start-up MO's Superfoods.
CBD firm Bod Australia has embarked on a first-of-its-kind clinical trial on medical cannabis for Tourette syndrome patients, while continuing to expand its supplements business in countries with a more conducive regulatory environment than its home market.
Australia supplements giant Blackmores has announced weak Q3 results thanks to slower domestic and China sales, but the firm is confident its new development strategies will get it back on track.
New Zealand probiotics firm BLIS Technologies has its eye on new product development and APAC growth, spurred by its recent financial performance and an additional Australian regulatory approval.
Australian firm Freedom Foods has started lactoferrin production at its Shepparton plant, with the goal of commencing sales of its lactoferrin in Q4 2019.
Read about who won big at Natural Health Products New Zealand industry awards, China's crackdown on health foods and probiotics regulations, and the latest research and innovations in the Oceanic region.
A new study has highlighted the deterioration of diets as Australian women age, but one author has questioned the need for protein supplements and functional foods to offset the decline.
Read about latest the regulatory developments in China, Blackmores' acerbic response to the MBA's "attack" on complementary medicine, and the mystery of India's missing fortified flour in our regulatory review.
The Medical Board of Australia's (MBA) proposal to reassess the regulation of complementary medicines and practitioners who prescribe them has elicited a strongly worded response from Marcus Blackmore.
Kiwi food technology company Ārepa has plans to become "the world's most iconic brain health brand", with its patented nootropic formula and science-backed claims driving this goal.
The recent slew of crackdowns, regulatory reviews and stricter rules for China's health food and supplement industry are 'growing pains' the industry must overcome, as regulators double down on efforts to promote safety and collect taxes.
Pure plant matter should be prioritised over botanical extracts if herbal supplement makers hope to achieve longevity in the industry, according to one industry player which is seeing its wholly plant-based supplements business soar
Quantec, Go Healthy, Anagenix and OneOne Health Group were the big winners at the industry awards event held by Natural Health Products New Zealand at its annual summit.
In light of an imminent $8m IPO, manufacturer Australian Nutrition & Sports (ANS) says it will focus on building its brand in its home nation and the China market before going down the daigou route.
